References
- Lankin V. The enzymatic systems in the regulation of free radical lipid peroxidation. Free radicals, nitric oxide, and inflammation: Molecular, biochemical, and clinical aspects. Amsterdam: IOS Press; 2003, NATO Science Series 344. 8–23.
- Lankin V, Tikhaze A. Free radical lipoperoxidation during atherosclerosis and antioxidative therapy of this disease. Free radicals, nitric oxide, and inflammation: Molecular, biochemical, and clinical aspects. Amsterdam: IOS Press; 2003, NATO Science Series 344. 218–231.
- Lankin VZ, Tikhaze AK, Kukharchuk VV, Konovalova GG, Pisarenko OI, Kaminnyi AI, . Antioxidants decrease the intensification of low density lipoprotein free radical peroxidation during therapy with statins. Mol Cell Biochem. 2003; 249 Suppl 1/2:129–140.
- Lankin VZ, Tikhaze AK, Kapel’ko VI, Shepel’kova GS, Shumaev KB, Panasenko OM, . Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress. Biochemistry. 2007;72 Suppl 10:1081–1090.
- Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, . Oxidative stress in atherosclerosis and diabetes. Bull Exp Biol Med. 2005;140 Suppl 1:41–43.
- Nedosugova LV, Lankin VZ, Balabolkin MI, Konovalova GG, Lisina MO, Antonova KV, . Interrelation between compensation of carbohydrate metabolism and severity of manifestations of oxidative stress in type II diabetes mellitus. Bull Exp Biol Med. 2003;136 Suppl 2:132–134.
- Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol. 2006;97 Suppl 5:640–645.
- Girona J, Manzaranes JM, Marimon F, Cabre A, Heras M, Guardiola M, . Oxidized to non-oxidized lipoprotein ratios are associated with atherosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis. 2007;18 Suppl 5:380–387.
- Imazu M, Ono K, Tadehara F, Kajiwara K, Yamamoto H, Sumii K, . Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome. Int Heart J. 2008;49 Suppl 5:515–524.
- Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, . Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis Circulation. 2008;118 Suppl 1:75–83.
- Rietzschei ER, Langlois M, De Buyzere ML, Segers P, De Bacquer D, Bekaert S, . Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations. Hypertension. 2008;52 Suppl 3:535–541.
- Protocol and Guidelines. Countrywide Integrated Noncommunicable Diseases Intervention (CINDI) Programme. Copenhagen: WHO Regional Office for Europe; 1996.
- Irodova NL, Lankin VZ, Konovalova GG, Kochetov AG, Chazova IE. Oxidative stress in patients with primary pulmonary hypertension. Bull Exp Biol Med. 2002;133 Suppl 6:580–582.
- Arzamastseva NE, Lankin VZ, Konovalova GG, Tikhaze AK, Ageev FT, Lapina YV, . Oxidative stress in patients with chronic heart failure and type II diabetes mellitus. Bull Exp Biol Med. 2007;143 Suppl 2:207–209.
- Sigurdardottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year old men (AIR Study). J Internal Med. 2002;252 Suppl 2:440–447.
- Verhoye E, Langlois MR. Circulating oxidized low-density lipoprotein: A biomarker of atherosclerosis and cardiovascular risk. Clin Chem Lab Med. 2009;47 Suppl 2:128–137.